Pancreatic Cancer

(asked on 9th September 2015) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what discussions he has had with NHS England on how the survival rates for pancreatic cancer are reflected in assessments of new treatments for that disease.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 14th September 2015

We have had no such discussions.

NHS England assesses new cancer drugs for inclusion on the national Cancer Drugs Fund (CDF) list in accordance with its CDF Standard Operating Procedures, which are available at:

www.england.nhs.uk/ourwork/pe/cdf/cdf-sop/

Reticulating Splines